So you've forgotten or unaware of the fact, that without manufacturing, treatment is dead on arrival. It's now very common to see pharmacies turning away customers, saying, "sorry, but your medication is on backorder." Let's take stimulant ADHD medication for example. Since December 2022, there's an ongoing shortage of all variant stimulant medications across the country, and no word yet, when supply will meet demand. There are cases, where people haven't been able to fill their scripts in 6 months. With schools starting, some parents have resorted to driving two hours across state lines, thinking, that there may be better luck in areas less populated. Congress, for some backwards logic, decided to grant fewer manufacturing licenses for this category drug, and look at the mess that ensued. We're talking some amphetamine mixed salts, not cryo tissue preservation, and we have power houses like Teva and Takeda unable to comment, when asked, "when things will return to normal?" So yeah, go on minimizing the crital role manufacturing plays when assessing the value of DCVAX. When you're in a war footing, you don't critic the method, but rather applaud the win. That's what matters at the end.
ILT
Market Data 
Markets 
